checkAd

    OBDUCAT.......QUO VADIS ??? (Seite 2450)

    eröffnet am 09.08.05 18:00:38 von
    neuester Beitrag 12.04.24 17:54:16 von
    Beiträge: 25.184
    ID: 998.804
    Aufrufe heute: 6
    Gesamt: 2.288.965
    Aktive User: 0

    ISIN: SE0000514705 · WKN: 922032 · Symbol: OBD
    0,0650
     
    EUR
    -45,83 %
    -0,0550 EUR
    Letzter Kurs 08:20:02 Frankfurt

    Werte aus der Branche Nanotechnologie

    WertpapierKursPerf. %
    178,88+1,20
    39,85+1,14
    34,15+0,77
    2,7450-0,72
    1,1500-0,86
    WertpapierKursPerf. %
    1,5100-2,58
    31,80-5,07
    1,0700-6,96
    0,6869-19,94
    2,0300-20,63

    Beitrag zu dieser Diskussion schreiben

     Durchsuchen
    • 1
    • 2450
    • 2519

    Begriffe und/oder Benutzer

     

    Top-Postings

     Ja Nein
      Avatar
      schrieb am 26.11.05 12:47:32
      Beitrag Nr. 694 ()
      @charly_2,@mctobi
      ich bewerte eure Postings (#691,#692) wie folgt:
      1) wer von seinen großen Erfolgen bei anderen Aktien schwärmt, hat meistens viel mehr Mißerfolge vorzuweisen, von denen er nicht spricht.
      2)ich könnte wetten, das Ihr in einem Jahr folgendes sagt:
      "Tja, wer auf mich hört macht Gewinne! Und übrigens meine Kursrakete Obducat ist von 0,13 auf 1,00 € gestiegen.!"
      :)
      MA
      Avatar
      schrieb am 26.11.05 11:55:43
      Beitrag Nr. 693 ()
      [posting]18.986.844 von marcoandre am 25.11.05 20:31:23[/posting]Wahnsinn, da wäre ich nie drauf gekommen. Dir entgeht wohl nichts ?? :)


      @ Charly, mctobi

      Ich kann euch gut verstehen. Am Wochenende ist es immer sehr bitter wenn man ganz alleine zu Hause herumsitzt und einem die Decke auf den Kopf fällt. Da ist man froh das es das Internet gibt. Und um die Weihnachtszeit ist es immer besonders schlimm. :cry:

      Ich wünsche euch trotzdem einen schönen 1. Advent. :D
      Avatar
      schrieb am 26.11.05 11:38:23
      Beitrag Nr. 692 ()
      [posting]18.996.424 von mctobi am 26.11.05 11:31:39[/posting]...und meine Globetel von 1.30 auf 3 Bucks, rechne ! :cool:

      Charly
      Avatar
      schrieb am 26.11.05 11:31:39
      Beitrag Nr. 691 ()
      Tja, wer auf mctobi hört, hat macht Gewinne !!!

      Bei 20 Cent habe ich gesagt Obducat verkaufen, weil es nochmal bis auf 10 Cent runtergehen wird....

      aber leute a la baroni..etc. sahen ja schon Kursziele von 1 Euro :laugh::laugh::laugh:

      Und übrigens meine Kursrakete Harmony ist nun 130% gestiegen, seit ich sie hier empfohlen habe....

      gruss
      tobi
      Avatar
      schrieb am 26.11.05 11:14:34
      Beitrag Nr. 690 ()
      Cooler Nickname, passt zur Frittenbude die laufend absäuft - ATL nix mehr weit :D

      Charly

      Trading Spotlight

      Anzeige
      Nurexone Biologic
      0,4200EUR +2,44 %
      Die bessere Technologie im Pennystock-Kleid?!mehr zur Aktie »
      Avatar
      schrieb am 26.11.05 01:29:39
      Beitrag Nr. 689 ()
      [posting]18.984.281 von tomhead am 25.11.05 18:10:22[/posting]@ tom,

      das war wirklich ein interessanter Hinweis. Danke!

      Wenn die Konferenz in größeren Expertenkreisen wirklich Beachtung findet, dann sollte sich ein "Durchfallen" von Obducat danach im Kurs sehr bald zeigen, genauso wie natürlich eine positive Einschätzung.

      Aus meiner persönlichen Kenntnis internationaler Meetings, auch in den USA, sind die exklusiven (kleinen) für die Zukunft oft sehr viel bedeutender, als die großen.

      Kannst Du in dieser Frage (Ergebnis?) online bleiben? Und Deine Recherchen dann auch hier kommunizieren? Das wäre toll!

      gruß, confi
      Avatar
      schrieb am 26.11.05 01:12:34
      Beitrag Nr. 688 ()
      [posting]18.979.844 von marcoandre am 25.11.05 14:20:38[/posting]:rolleyes::rolleyes::rolleyes::rolleyes::rolleyes::rolleyes:
      Avatar
      schrieb am 25.11.05 20:31:23
      Beitrag Nr. 687 ()
      [posting]18.985.861 von KYPROS am 25.11.05 19:33:37[/posting]Glückwunsch! Du hast heute Einjähriges (siehe Info Button).
      :)
      MA
      Avatar
      schrieb am 25.11.05 19:33:37
      Beitrag Nr. 686 ()
      @ MA

      Habe deine Einladung leider zu spät gelesen, wird aber auf der 1 Euro-Party garantiert nachgeholt. ;)

      @ tomhead

      Liest sich gut. :)
      Avatar
      schrieb am 25.11.05 18:10:22
      Beitrag Nr. 685 ()
      @all

      noch eine kleine Info: das Interessante habe ich fett markiert:

      Wall Street Reporter Hosting SUPER STOCK CHALLENGE Conference December 8, 2005 -- New York City
      Premier Conference Series Showcasing Today`s Most Exciting Micro-Cap Stocks

      NEW YORK, NY -- (MARKET WIRE) -- 11/23/2005 -- Fund managers, analysts, and investors will convene in New York City on Thursday, December 8, 2005, for the "Super Stock Challenge" investment conference, hosted by Wall Street Reporter Magazine.

      Decision-makers from hedge funds and investment firms will be on hand at this exciting event to listen to presentations from CEOs of six rapidly emerging technology and biomedical firms, including:

      - Dynamic Health Products Inc.(OTC BB: DYHP) Generating nearly $25 million in revenues during the past 6 months, DYHP is a rapidly growing distributor in the sports nutrition product and performance drink industries and is engaged in developing, wholesaling and distributing a wide variety of non-prescription drugs, dietary supplements, vitamins, health food and nutritional products, soft goods and other related products. CEO, Mandeep Taneja, will discuss the company`s growth strategy for the coming year.

      - Obducat AB -- Based in Malmo, Sweden, Obucat is one of the most established companies in the Nanotechnology sector. Obducat develops and supplies technologies and processes for production and analysis of micro and nano structures and provides solutions to companies working with information storage, semiconductors, printed circuit boards, and sensors. Obducat`s technologies include equipment for nano imprint lithography, electron beam lithography, and electron beam microscopy, as well as patented process know-how available for licensing. Obducat CEO Patrik Lundstrom will discuss the company`s products, technologies, and growth strategy. This will be Obducat`s first presentation to U.S. investors!

      - Kuhlman Company (OTC BB: KHLM) is a specialty men`s and women`s apparel retailer, which is rapidly building a national chain of stores. Revenues are up 137% in the most recent 9 months. Kuhlman opened its first retail store in July 2003 and now operates forty one (41) retail stores in 17 states. What`s in store for the future? CEO Scott Kuhlman will share his unique vision, and corporate growth outlook.

      - Smart Online Inc.(OTC BB: SOLN) -Smart Online`s OneBiz(SM) Platform offers a comprehensive, Web-native business suite, enabeling organizations to operate more efficiently through the use of integrated applications. Users access a simple-to-use, customizable "Dashboard" for a single view of daily business activities and integrated business applications and workflow modules. CEO Michael Nouri will talk about his company`s technology platform, and profit potential.

      - Aeolus Pharmaceuticals Inc. (OTC BB: AOLS) is developing a pipeline of therapeutic agents based on its proprietary small molecule catalytic antioxidants, targeting Parkinson`s disease, Autoimmune disorders (arthritis and ulcerative colitis) Chronic Obstructive Lung Disease; Biodefense/Radioprotection; Tumor Suppression/Bone Marrow Transplantation; and Stroke. Aeolus CEO, Richard P. Burgoon will fill you in on the company`s latest clinical developments.

      The Conference will commence with breakfast at 7:30AM and is scheduled to conclude at 12:00PM. Investment professionals are invited to attend the Conference, and can register at www.wallstreetreporter.com/sdc3

      Wall Street Reporter`s SUPER STOCK CHALLENGE Investment Conference offers an unparalleled opportunity to gain insight into new trends and investment opportunities in the micro/small-cap marketplace. Research in follow-up to past Wall Street Reporter conferences indicates that companies presenting have experienced an average stock price increase of 30% in the four to eight weeks following their appearance.

      The popularity of the sold-out Conference within the financial community stems from its unique format, which melds traditional investment conference practices with an unrehearsed, candid, and entirely objective Q&A session with a judge`s panel of veteran investment fund managers and analysts. The judges panels are directed to challenge the fundamentals of the CEOs` presentations from an investor`s perspective -- much like judges on a reality television show -- thereby allowing companies with strong and compelling stories to shine while exposing weaknesses where they exist.

      "Presenting at the SUPER STOCK CHALLENGE is not for the CEO who is faint of heart," said Jack Marks, Publisher of Wall Street Reporter Magazine. "The analyst panels present questions that can cut to the core of a company`s business model. This is the antithesis of the `softball` Q&A that many business leaders have grown accustomed to. But for those CEOs with a strong business case and a solid story, the upside of presenting at the SUPER STOCK CHALLENGE can be enormous."

      Many companies that have presented in the past have seen stock price increases of more than 50-300% in the weeks following the Conference.

      "My sense is that the share price increases are attributable to the quality of companies attracted to our format more than anything else," continued Marks. "Over the years, the conference has helped expose both great successes in the making as well as those companies whose strategy and/or timing may be in need of recalibrating. What makes the conferences great is that no matter the outcome, the insight gleaned by audience, presenters, and panelists is invaluable -- and often entertaining and unexpected."

      The event will also be Web cast live on www.vcall.com.

      Registration for attending conference in-person is at www.wallstreetreporter.com/sdc3

      About Wall Street Reporter Magazine:

      Wall Street Reporter Magazine (est. 1843) is the leading provider of in-depth and unscripted CEO interviews to the global investment community. More than 80,000 portfolio managers, analysts, venture capitalists, management consultants, government leaders, reporters, media executives, and other decision makers read Wall Street Reporter publications. For more information, visit www.wallstreetreporter.com
      • 1
      • 2450
      • 2519
       DurchsuchenBeitrag schreiben


      OBDUCAT.......QUO VADIS ???